Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julia Sauer has a total of 112 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identification of a NUAK1/2 Inhibitor as a Macrophage-Polarizing Compound by a Machine Learning-Based Phenotypic Cell Painting Screen

    by Johanna B. Brüggenthies-Brunner, Jakob Dittmer, Julia Sauer, Sarah Groetzner, Anika Liu, Eva Martin, Anja Teufel, Christine Strasser, Helga Bronner, Robert Ries, et al.

    Disease-associated macrophage states contribute to the pathogenesis of numerous inflammatory disorders. While small molecule-mediated macrophage repolarization represents a promising strategy to restore homeostasis, current approaches often rely on predefined molecular markers and may therefore overlook previously unrecognized modulators of macrophage plasticity. To address this limitation, we performed a phenotypic high-content cell painting screen in induced pluripotent stem cell-derived and blood monocyte-derived macrophages. Using our previously established machine learning-based cell painting analysis pipeline, we screened the annotated opnMe and JUMP-CP compound libraries and identified 26 compounds that induced M1- or M2-like polarization phenotypes. Among these hits, we identified WZ4003, an inhibitor of AMPK-related kinases NUAK1 and NUAK2, as novel macrophage-polarizing compound. Combining cell painting feature profiling with functional analyses, we revealed that the NUAK1/2 inhibitor WZ4003 induces a distinct macrophage state characterized by a rounded M1-like morphology, ferroptosis protection, mitochondrial reactive oxygen species increase, antioxidative adaptation, and phagocytosis and efferocytosis impairment. These findings link specific morphological signatures to functional macrophage states. Overall, this study provides a resource of macrophage-polarizing compounds and demonstrates the utility of machine learning-based cell painting for identifying novel modulators of macrophage polarization states.

  • Open Access

    Metabolic adaptations of inflammatory macrophages govern ferroptosis susceptibility via the GCH1–BH4–iNOS axis

    by Julia Sauer, Patricia P Ogger, Jasmina Dukic, Alina Nessensohn, Svenja Gabler, Ann-Katrin Schwenzer, Julia Kirstin Unsöld, Birgit Maria Cortès, Barbara Steigenberger, Nuria Fernandez Perez, et al.

    In inflammatory tissue niches, macrophages encounter intense oxidative stress due to their own production of reactive oxygen and nitrogen species as part of antimicrobial defense. Our findings reveal that inflammatory macrophages deploy distinct, context-dependent redox-protective mechanisms to survive this self-inflicted stress, thereby avoiding ferroptotic cell death. Specifically, LPS-activated macrophages, M(LPS), rely on the GTP cyclohydrolase 1 (GCH1)–tetrahydrobiopterin (BH4) pathway for ferroptosis resistance, whereas LPS + IFN-γ–activated macrophages, M(LPS–IFN-γ), depend primarily on nitric oxide produced by inducible nitric oxide synthase (iNOS)—with the BH4 pathway suppressing cell death in the absence of nitric oxide. These distinct adaptations highlight a novel GCH1–BH4–iNOS axis that governs macrophage ferroptosis susceptibility. In both the LPS or the LPS + IFN-γ–activated settings, the redox-protective phenotype is reversible: Removal of inflammatory stimuli abolishes the protection, indicating that this metabolic programming requires continuous stimulation and is not a permanently fixed state. These findings uncover redox metabolism-guided metabolic distinctions between inflammatory macrophages and reveal how they preserve viability over prolonged inflammatory activation. Ultimately, our findings establish the GCH1–BH4–iNOS axis as a central, targetable mechanism to manipulate macrophage ferroptosis resistance for therapeutic purposes.


    • 14 April 2026

    Antibodies to connective tissue growth factor (ctgf) and uses thereof

    by Andreas-David Brunner, Lars Dittus, Priyanka Gupta, Muriel Lize, Maria Bonatsakis Myzithras, Irina Rybina, Julia Sauer, Wioletta Anna Skronska-Wasek, Heiko Friedrich Stahl

  • iPSC-derived macrophages: An in vitro model to study human disease-relevant macrophage biology

    by Julia Sauer, Daniela Schloesser, Katja Koeppen, Katrin Fundel-Clemens, Chantelle Simone-Roach, Kristen Hall, Aleksandra Ivovic, Jeffrey Makings, Daniela Reiss, Michael Traub, et al.

    Human macrophages differ from their mouse counterparts in multiple metabolic pathways, surface protein expression, and transcription factor biology. Monocyte-derived macrophages (MDMs) from blood are generally used to study human macrophage biology in vitro. However, the use of MDMs as a human macrophage model is limited by donor-to-donor variability, total cell availability, preactivation effects, and relative resistance to genetic manipulation. Here, we explored stem cell–derived macrophages to study in vitro disease-relevant macrophage phenotypes. We compared induced pluripotent stem cell–derived macrophages (iDMs) with primary human stem cell–derived macrophages from cord blood–derived macrophages or bone marrow–derived macrophages (BMDMs) in their ability to elaborate tissue and disease-relevant phenotypes in comparison with conventional blood MDMs. Analyses of phenotypical and functional features revealed that iDMs were highly similar to cord blood–derived macrophages and BMDMs, and resembled MDMs. Importantly, all macrophages, and particularly iDMs adopted expected disease-relevant phenotypes in vitro when stimulated with disease-associated mediators. RNA sequencing analyses of in vitro macrophages stimulated with tissue relevant factors revealed that their transcriptomes mapped to human in vivo inflammatory conditions. Using this approach, we found a close correlation between stimulation and expected disease-association counterpart in vivo. In conclusion, we established a streamlined system to link stem cell–derived macrophage phenotypes to relevant macrophage phenotypes in disease states. Thus, enabling conditions for in vitro replication of complex human macrophage biology observed in single-cell RNA sequencing from human diseased tissue.


  • Role of Ferroptosis in the interplay between metabolically distinct macrophages and lungs cells in the context of Idiopathic Pulmonary Fibrosis

    by Julia Sauer, Christoph Mayr, Lukasz Boryn, Patricia Ogger, Matthew Thomas, Karim El Kasmi, Peter Murray, Wioletta Skronska-Wasek

    Idiopathic Pulmonary Fibrosis (IPF), a major global health issue, is marked by epithelial dysfunction, fibroblast activation, extracellular matrix accumulation, and macrophages playing crucial role in the deranged communication. Macrophage phenotypes, defined by distinct metabolic states, have been shown to impact neighboring cells, including protection from ferroptosis, an iron-dependent cell death due to redox imbalance. Interestingly, elevated Fe2+ levels in IPF were found to correlate with lung fibrosis. In this study we aimed to investigate the role of ferroptosis in IPF pathogenesis. To this end we utilized spatial and single cell transcriptomic analyses and could show ferroptotic activity in fibrotic but not in healthy tissue. FABP4+ macrophages, previously shown not protect neighboring cells from ferroptosis, were found to be adjacent to pro-ferroptotic AT1 and AT2 cells, suggesting their role in alveolar cell loss in IPF. On the other hand, SPP1 macrophages, providing ferroptosis protection, were found near ciliated and club cells, shown to be upregulated in IPF. Additionally, ferroptotic activity in fibroblasts was linked to disease severity, with pro-ferroptotic cells in less fibrotic areas, opposite to cells located in severely affected regions showing lower ferroptotic activity. Collectively, we propose here a new role for ferroptosis in IPF pathogenesis and a central role of macrophages in lung cell survival. Thus, manipulating macrophage metabolic states represents a promising IPF treatment approach.

  • Open Access

    Insights into the Identification of iPSC- and Monocyte-Derived Macrophage-Polarizing Compounds by AI-Fueled Cell Painting Analysis Tools

    by Johanna B. Brüggenthies, Jakob Dittmer, Eva Martin, Igor Zingman, Ibrahim Tabet, Helga Bronner, Sarah Groetzner, Julia Sauer, Mozhgan Dehghan Harati, Rebekka Scharnowski, et al.

    Macrophage polarization critically contributes to a multitude of human pathologies. Hence, modulating macrophage polarization is a promising approach with enormous therapeutic potential. Macrophages are characterized by a remarkable functional and phenotypic plasticity, with pro-inflammatory (M1) and anti-inflammatory (M2) states at the extremes of a multidimensional polarization spectrum. Cell morphology is a major indicator for macrophage activation, describing M1(-like) (rounded) and M2(-like) (elongated) states by different cell shapes. Here, we introduced cell painting of macrophages to better reflect their multifaceted plasticity and associated phenotypes beyond the rigid dichotomous M1/M2 classification. Using high-content imaging, we established deep learning- and feature-based cell painting image analysis tools to elucidate cellular fingerprints that inform about subtle phenotypes of human blood monocyte-derived and iPSC-derived macrophages that are characterized as screening surrogate. Moreover, we show that cell painting feature profiling is suitable for identifying inter-donor variance to describe the relevance of the morphology feature ‘cell roundness’ and dissect distinct macrophage polarization signatures after stimulation with known biological or small-molecule modulators of macrophage (re-)polarization. Our novel established AI-fueled cell painting analysis tools provide a resource for high-content-based drug screening and candidate profiling, which set the stage for identifying novel modulators for macrophage (re-)polarization in health and disease.


  • Open Access

    Diverse potential of secretome from natural killer cells and monocyte-derived macrophages in activating stellate cells

    by Julia Sauer, Agnes A. Steixner-Kumar, Svenja Gabler, Maciej Motyka, Jörg F. Rippmann, Stefan Brosa, Dennis Boettner, Tanja Schönberger, Charlotte Lempp, Vanessa Frodermann, et al.

    Chronic liver diseases, such as non-alcoholic steatohepatitis (NASH)-induced cirrhosis, are characterized by an increasing accumulation of stressed, damaged, or dying hepatocytes. Hepatocyte damage triggers the activation of resident immune cells, such as Kupffer cells (KC), as well as the recruitment of immune cells from the circulation toward areas of inflammation. After infiltration, monocytes differentiate into monocyte-derived macrophages (MoMF) which are functionally distinct from resident KC. We herein aim to compare the in vitro signatures of polarized macrophages and activated hepatic stellate cells (HSC) with ex vivo-derived disease signatures from human NASH. Furthermore, to shed more light on HSC activation and liver fibrosis progression, we investigate the effects of the secretome from primary human monocytes, macrophages, and NK cells on HSC activation. Interleukin (IL)-4 and IL-13 treatment induced transforming growth factor beta 1 (TGF-β1) secretion by macrophages. However, the supernatant transfer did not induce HSC activation. Interestingly, PMA-activated macrophages showed strong induction of the fibrosis response genes COL10A1 and CTGF, while the supernatant of IL-4/IL-13-treated monocytes induced the upregulation of COL3A1 in HSC. The supernatant of PMA-activated NK cells had the strongest effect on COL10A1 induction in HSC, while IL-15-stimulated NK cells reduced the expression of COL1A1 and CTGF. These data indicate that other factors, aside from the well-known cytokines and chemokines, might potentially be stronger contributors to the activation of HSCs and induction of a fibrotic response, indicating a more diverse and complex role of monocytes, macrophages, and NK cells in liver fibrosis progression.


  • Pro-fibrotic macrophages escape redox associated cell death by upregulation of anti-ferroptotic metabolic pathways

    by J Sauer, P Ogger, C K Watson, A Nessensohn, D Schlösser, W Skronska-Wasek, M J Thomas, P J Murray, K C El Kasmi

    Increasing evidence suggests macrophages play a crucial role in fibrosis pathogenesis, including lung fibrosis. Understanding mechanisms that underly pro-fibrotic macrophage can help identify new drug targets for anti-fibrotic therapies. Lung fibrosis has been associated with oxidative stress. Here, we hypothesize that pro-fibrotic macrophages have distinct metabolic adaptations aiding their survival under conditions of oxidative stress. In vitro exposure of human primary macrophages to pro-fibrotic (IL4/IL13+TNFα) and pro-reparative (IL4/IL13) cytokine cocktails induced transcriptional phenotypes resembling those found in respective macrophage populations in lungs of patients with idiopathic pulmonary fibrosis (IPF). Multi-omics analysis revealed distinct expression patterns of redox balance-associated regulators involved in ferroptosis, in homeostatic and fibrotic primary human macrophages. Importantly, these metabolic pathways were also observed in fibrotic and reparative macrophages in fibrotic lungs. Inhibitors were used to test the relevance of these metabolic adaptations to cellular survival and ferroptosis sensitivity in pro-fibrotic and pro-reparative macrophages. Pro-fibrotic macrophages exhibited a priori protection from ferroptosis, in contrast to pro-reparative macrophages. Mechanistically, this protection could be linked to the expression of GPX4 and GCH1 pathways, known regulators of ferroptosis protection in cancer cells. We found that pro-fibrotic macrophages adapt metabolically to resist redox stress-related cell death. This reveals new metabolic regulators in pro-fibrotic macrophages offering potential drug targets for managing fibrosis.

  • Open Access

    Application of human iPSC-derived macrophages in a miniaturized high-content-imaging-based efferocytosis assay

    by Sarah Bitzer, Mozhgan Dehghan Harati, Karim C. El Kasmi, Daniela Schloesser, Julia Sauer, Heiko Olbrich, Michael Schuler, Florian Gantner, Ralf Heilker


  • Open Access

    Senescent cells suppress macrophage-mediated corpse removal via upregulation of the CD47-QPCT/L axis

    by Daniela Schloesser, Laura Lindenthal, Julia Sauer, Kyoung-Jin Chung, Triantafyllos Chavakis, Eva Griesser, Praveen Baskaran, Ulrike Maier-Habelsberger, Katrin Fundel-Clemens, Ines Schlotthauer, et al.

    Progressive accrual of senescent cells in aging and chronic diseases is associated with detrimental effects in tissue homeostasis. We found that senescent fibroblasts and epithelia were not only refractory to macrophage-mediated engulfment and removal, but they also paralyzed the ability of macrophages to remove bystander apoptotic corpses. Senescent cell-mediated efferocytosis suppression (SCES) was independent of the senescence-associated secretory phenotype (SASP) but instead required direct contact between macrophages and senescent cells. SCES involved augmented senescent cell expression of CD47 coinciding with increased CD47-modifying enzymes QPCT/L. SCES was reversible by interfering with the SIRPα-CD47-SHP-1 axis or QPCT/L activity. While CD47 expression increased in human and mouse senescent cells in vitro and in vivo, another ITIM-containing protein, CD24, contributed to SCES specifically in human epithelial senescent cells where it compensated for genetic deficiency in CD47. Thus, CD47 and CD24 link the pathogenic effects of senescent cells to homeostatic macrophage functions, such as efferocytosis, which we hypothesize must occur efficiently to maintain tissue homeostasis.